(NYSEMKT: INFU) Infusystem Holdings's forecast annual revenue growth rate of 4.15% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.14%.
Infusystem Holdings's revenue in 2026 is $142,404,000.On average, 6 Wall Street analysts forecast INFU's revenue for 2026 to be $2,981,644,801, with the lowest INFU revenue forecast at $2,848,041,927, and the highest INFU revenue forecast at $3,087,598,742. On average, 7 Wall Street analysts forecast INFU's revenue for 2027 to be $3,205,863,522, with the lowest INFU revenue forecast at $3,039,969,923, and the highest INFU revenue forecast at $3,401,222,407.
In 2027, INFU is forecast to generate $3,205,258,070 in revenue, with the lowest revenue forecast at $3,010,302,819 and the highest revenue forecast at $3,424,431,365.